Nath Bio-Genes

{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "160.04",
    "chg": 1.07,
    "chgp": "0.67%",
    "dir": 1,
    "prev_price": "158.97",
    "mcapval": "299.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "sector_id": 53,
    "indexname": "India SENSEX",
    "isin": "INE448G01010",
    "curr_date": "Jul 17, 04:00 PM",
    "curr_time": "16:52 PM",
    "last_traded_at": "Jul 17, 04:00 PM IST",
    "bse_nse_vol": "10.64 k",
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nath-bio-genes-628630-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4103595",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NathBioGenesInd_mojoScore_4103595.png",
        "date": "2026-07-15 10:11:30",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4088270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NathBioGenesInd_mojoScore_4088270.png",
        "date": "2026-07-04 10:10:47",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with the most up-to-date analysis."
      },
      {
        "title": "Nath Bio-Genes Downgraded to Sell Amid Weak Fundamentals and Mixed Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-sell-amid-weak-fundamentals-and-mixed-technicals-4068418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_mojoScore_4068418.png",
        "date": "2026-06-23 08:42:02",
        "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This adjustment reflects a complex interplay of factors including a shift in technical indicators, subdued financial trends, valuation considerations, and overall quality assessments. Despite a modest uptick in share price, the company’s long-term fundamentals and market performance continue to raise concerns for investors."
      },
      {
        "title": "Nath Bio-Genes Upgraded to Hold as Technicals Improve Amid Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-upgraded-to-hold-as-technicals-improve-amid-flat-financials-4055433",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_mojoScore_4055433.png",
        "date": "2026-06-16 08:46:15",
        "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating upgraded from Sell to Hold as of 15 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to face challenges in long-term growth and profitability, recent technical indicators and valuation metrics have improved sufficiently to warrant a more cautious but optimistic stance."
      },
      {
        "title": "Nath Bio-Genes Falls 3.53%: 2 Key Factors Driving This Week’s Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-falls-353-2-key-factors-driving-this-weeks-decline-4052376",
        "imagepath": "",
        "date": "2026-06-13 17:21:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Formation of Golden Cross signalling potential bullish breakout</p>\n                    <p><strong>2 June:</strong> Upgrade to Hold rating by MarketsMOJO on technical and valuation improvements</p>\n                    <p><strong>5 June:</strong> Stock closes the week lower at Rs.169.35 (-3.53%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.175.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.169.35</div><div class=\"stat-change negative\">-3.53%</div></div>\n     ..."
      },
      {
        "title": "Nath Bio-Genes Downgraded to Sell Amid Flat Financials and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-sell-amid-flat-financials-and-weak-fundamentals-4040521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_mojoScore_4040521.png",
        "date": "2026-06-09 08:52:03",
        "description": "Nath Bio-Genes (India) Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 8 June 2026, reflecting concerns over its stagnant financial performance, weak long-term fundamentals, and consistent underperformance against market benchmarks. Despite a very attractive valuation, the company’s deteriorating financial trends and technical indicators have prompted a cautious stance from analysts."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd Upgraded to Hold on Technical and Valuation Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-4030270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_mojoScore_4030270.png",
        "date": "2026-06-02 09:05:41",
        "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating upgraded from Sell to Hold as of 1 June 2026. This change reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite persistent challenges in long-term fundamentals, recent technical signals and valuation metrics have improved sufficiently to warrant a more cautious but optimistic stance."
      },
      {
        "title": "Golden Cross Confirmed: Do Nath Bio-Genes' Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-forms-golden-cross-signalling-potential-bullish-breakout-4027111",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NathBioGenesInd_goldencross_4027111.png",
        "date": "2026-06-01 18:00:30",
        "description": "The 50-day moving average for Nath Bio-Genes (India) Ltd has crossed above the 200-day moving average, signalling a golden cross on 1 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a more nuanced picture that merits careful analysis."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-4004876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_mojoScore_4004876.png",
        "date": "2026-05-22 10:10:40",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company's performance and outlook."
      }
    ],
    "total": 174,
    "sid": "628630",
    "stock_news_url": "https://www.marketsmojo.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Related Party Transaction for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Other General Purpose",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding Investor Presentation on unaudited financial results for the period ended 30th sep 2019",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Investor Presentation",
      "datetime": "04-Nov-2019"
    },
    {
      "details": "Nath Bio-Genes (India) Limited has informed the Exchange regarding 'Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.'.",
      "source": "NSE",
      "caption": "Nath Bio-Genes (India) Limited - Updates",
      "datetime": "30-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nath Bio-Genes (India) Ltd is Rated Sell

2026-07-15 10:11:30

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-07-04 10:10:47

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with the most up-to-date analysis.

Read full news article

Nath Bio-Genes Downgraded to Sell Amid Weak Fundamentals and Mixed Technicals

2026-06-23 08:42:02

Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This adjustment reflects a complex interplay of factors including a shift in technical indicators, subdued financial trends, valuation considerations, and overall quality assessments. Despite a modest uptick in share price, the company’s long-term fundamentals and market performance continue to raise concerns for investors.

Read full news article

Nath Bio-Genes Upgraded to Hold as Technicals Improve Amid Flat Financials

2026-06-16 08:46:15

Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating upgraded from Sell to Hold as of 15 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to face challenges in long-term growth and profitability, recent technical indicators and valuation metrics have improved sufficiently to warrant a more cautious but optimistic stance.

Read full news article

Nath Bio-Genes Falls 3.53%: 2 Key Factors Driving This Week’s Decline

2026-06-13 17:21:45

Key Events This Week

1 June: Formation of Golden Cross signalling potential bullish breakout

2 June: Upgrade to Hold rating by MarketsMOJO on technical and valuation improvements

5 June: Stock closes the week lower at Rs.169.35 (-3.53%)

Week Open

Rs.175.55

Week Close

Rs.169.35

-3.53%

...

Read full news article

Nath Bio-Genes Downgraded to Sell Amid Flat Financials and Weak Fundamentals

2026-06-09 08:52:03

Nath Bio-Genes (India) Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 8 June 2026, reflecting concerns over its stagnant financial performance, weak long-term fundamentals, and consistent underperformance against market benchmarks. Despite a very attractive valuation, the company’s deteriorating financial trends and technical indicators have prompted a cautious stance from analysts.

Read full news article

Nath Bio-Genes (India) Ltd Upgraded to Hold on Technical and Valuation Improvements

2026-06-02 09:05:41

Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has seen its investment rating upgraded from Sell to Hold as of 1 June 2026. This change reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite persistent challenges in long-term fundamentals, recent technical signals and valuation metrics have improved sufficiently to warrant a more cautious but optimistic stance.

Read full news article

Golden Cross Confirmed: Do Nath Bio-Genes' Other Technical Indicators Agree?

2026-06-01 18:00:30

The 50-day moving average for Nath Bio-Genes (India) Ltd has crossed above the 200-day moving average, signalling a golden cross on 1 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a more nuanced picture that merits careful analysis.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-05-22 10:10:40

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

View All News